~~<i id='084E86449A'><strike id='084E86449A'><tt id='084E86449A'><pre id='084E86449A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：Wikipedia 2025-09-30 00:39:39 - browse：96

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Will the FTC rein in IQVIA's health data empire?

focus

entertainment

focus

entertainment

knowledge

1:23FileimageofambulancesparkedinfrontoftheemergencyentrancetoMt.Sinai,BethIsraelHospital,NewYorkCit

WSS

Maui's cultural, historic landmarks damaged in the devastating wildfires

Wegovy’s successful heart trial raises vital question about weight loss

Methadone doses haven’t kept up in the age of fentanyl

Former reverend arrested for allegedly killing 8

Friends ask where James Watson's attitudes about race came from

NIH trials fail to test meaningful long Covid therapies, experts say

focus

knowledge

focus

Sports medicine is finally prioritizing gender equality

Why failed clinical trials don’t always spell doom for a new drug

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA panel issues narrow recommendation for Covid vaccine booster doses

BioMarin wins approval for gene therapy to treat hemophilia A

'Investigate these claims': UFO transparency at center of House hearing

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Rise in cancer among younger people worries and puzzles doctors

Medical leaders decry Supreme Court decision on affirmative action

'Investigate these claims': UFO transparency at center of House hearing

entertainment

CDC Director Mandy Cohen on transparency, trust, and health

'Investigate these claims': UFO transparency at center of House hearing

Search called off for baby washed away in Pennsylvania flash flood

What to watch for from Zogenix and Amicus clinical trials

Naloxone nonprofit donates 200,000 doses after FDA approval

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

focus

entertainment

knowledge

knowledge